PMC Articles for MedGen (Select 1643731) - PMC

Links from MedGen

Items: 1 to 20 of 116

<< First< Prev

Page of 6

Select item 105141631.

The role of miR-139-5p in radioiodine-resistant thyroid cancer

V. Pecce, M. Sponziello, A. Verrienti, G. Grani, L. Abballe, S. Bini, S. Annunziata, G. Perotti, M. Salvatori, L. Zagaria, V. Maggisano, D. Russo, S. Filetti, C. Durante

J Endocrinol Invest. 2023; 46(10): 2079–2093. Published online 2023 Mar 18. doi: 10.1007/s40618-023-02059-7

PMCID:: PMC10514163

Article PubReader PDF–1.6M Cite

Select item 104232212.

Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer

Yeseong Hwang, Hyeok Jun Yun, Jae Woong Jeong, Minki Kim, Seyeon Joo, Hae-Kyung Lee, Hang-Seok Chang, Seok-Mo Kim, Sungsoon Fang

Cell Death Dis. 2023 Aug; 14(8): 515. Published online 2023 Aug 12. doi: 10.1038/s41419-023-06041-2

PMCID:: PMC10423221

Article PubReader PDF–6.8M Cite

Select item 104033893.

Add-on radioiodine during long-term BRAF/MEK inhibition in patients with RAI-refractory thyroid cancers: a reasonable option?

Filipe Miguel Montes de Jesus, Vittoria Espeli, Gaetano Paone, Luca Giovanella

Endocrine. 2023; 81(3): 450–454. Published online 2023 May 16. doi: 10.1007/s12020-023-03388-6

PMCID:: PMC10403389

Article PubReader PDF–453K Cite

Select item 103558724.

pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer

Mark Yarchoan, Changqing Ma, Andrea B. Troxel, Stephen J. Stopenski, Waixing Tang, Aaron B. Cohen, Marina Pappas-Paxinos, Burles A. Johnson, III, Emerson Y. Chen, Michael D. Feldman, Marcia S. Brose

Horm Cancer. 2016 Jun; 7(3): 188–195. Published online 2016 Mar 18. doi: 10.1007/s12672-016-0253-6

PMCID:: PMC10355872

Article PubReader PDF–1.4M Cite

Select item 103314705.

Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance

Sarah Hamidi, Marie-Claude Hofmann, Priyanka C. Iyer, Maria E. Cabanillas, Mimi I. Hu, Naifa L. Busaidy, Ramona Dadu

Front Endocrinol (Lausanne) 2023; 14: 1176731. Published online 2023 Jun 26. doi: 10.3389/fendo.2023.1176731

PMCID:: PMC10331470

Article PubReader PDF–2.4M Cite

Select item 101626836.

Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis

Julia I Staubitz, Celine Müller, Antonia Heymans, Christina Merten, Bianca Roos, Alicia Poplawski, Annekathrin Ludt, Stephanie Strobl, Erik Springer, Arno Schad, Wilfried Roth, Thomas J Musholt, Nils Hartmann

BJS Open. 2023 Jun; 7(3): zrad029. Published online 2023 May 5. doi: 10.1093/bjsopen/zrad029

PMCID:: PMC10162683

Article PubReader PDF–244K Cite

Select item 101064087.

Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy

Laura Boucai, Mahesh Saqcena, Fengshen Kuo, Ravinder K. Grewal, Nicholas Socci, Jeffrey A. Knauf, Gnana P. Krishnamoorthy, Mabel Ryder, Alan L. Ho, Ronald A. Ghossein, Luc G. T. Morris, Venkatraman Seshan, James A. Fagin

Clin Cancer Res. Author manuscript; available in PMC 2023 Oct 14.

Published in final edited form as: Clin Cancer Res. 2023 Apr 14; 29(8): 1620–1630. doi: 10.1158/1078-0432.CCR-22-2882

PMCID:: PMC10106408

Article PubReader PDF–1.5M Cite

Select item 99145488.

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na⁺/I⁻ Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells

Thoudam Debraj Singh, Jae Eon Lee, Kwang Hee Son, Bo Ra Lee, Sang Kyoon Kim, Deepak Gulwani, Vijaya Sarangthem, Yong Hyun Jeon

Cells. 2023 Feb; 12(3): 470. Published online 2023 Feb 1. doi: 10.3390/cells12030470

PMCID:: PMC9914548

Article PubReader PDF–3.1M Cite

Select item 98393159.

Tumor Microenvironment–Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer

Asumi Iesato, Carmelo Nucera

Adv Exp Med Biol. Author manuscript; available in PMC 2023 Jan 13.

Published in final edited form as: Adv Exp Med Biol. 2021; 1329: 253–269. doi: 10.1007/978-3-030-73119-9_14

PMCID:: PMC9839315

Article PubReader PDF–473K Cite

Select item 974478710.

Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data

Hui He, Shan Cong, Yu Wang, Qinghai Ji, Weiyan Liu, Ning Qu

Front Endocrinol (Lausanne) 2022; 13: 969914. Published online 2022 Nov 29. doi: 10.3389/fendo.2022.969914

PMCID:: PMC9744787

Article PubReader PDF–21M Cite

Select item 965861011.

Adam Maciejewski, Katarzyna Lacka

Int J Mol Sci. 2022 Nov; 23(21): 13661. Published online 2022 Nov 7. doi: 10.3390/ijms232113661

PMCID:: PMC9658610

Article PubReader PDF–1.0M Cite

Select item 959563112.

Dabrafenib Versus Dabrafenib + Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial

Naifa L. Busaidy, Bhavana Konda, Lai Wei, Lori J. Wirth, Catherine Devine, Gregory A. Daniels, Jonas A. DeSouza, Ming Poi, Nathan D. Seligson, Maria E. Cabanillas, Jennifer A. Sipos, Matthew D. Ringel, Ann-Kathrin Eisfeld, Cynthia Timmers, Manisha H. Shah

Thyroid. October 2022; 32(10): 1184–1192. Published online 2022 Oct 14. doi: 10.1089/thy.2022.0115

PMCID:: PMC9595631

Article PubReader PDF–805K Cite

Select item 952750113.

Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study

Manuel Weber, David Kersting, Burkhard Riemann, Tim Brandenburg, Dagmar Führer-Sakel, Frank Grünwald, Michael C. Kreissl, Henning Dralle, Frank Weber, Kurt Werner Schmid, Ken Herrmann, Walter Jentzen, Hong Grafe, Christoph Rischpler, Sarah Theurer, Andreas Bockisch, James Nagarajah, Wolfgang P. Fendler

Clin Cancer Res. 2022 Oct 3; 28(19): 4194–4202. Published online 2022 May 20. doi: 10.1158/1078-0432.CCR-22-0437

PMCID:: PMC9527501

Article PubReader PDF–566K Cite

Select item 952607614.

A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer

Ying Ding, Peng Li, Wenlong Wang, Fang Liu

Dis Markers. 2022; 2022: 8735551. Published online 2022 Aug 30. doi: 10.1155/2022/8735551

PMCID:: PMC9526076

Article PubReader PDF–5.4M Cite

Select item 940905315.

Comparison of the Therapeutic Effects of [²¹¹At]NaAt and [¹³¹I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model

Tadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, Tatsuhiko Sato, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Eku Shimosegawa, Yang Wang, Hiromitsu Haba, Takashi Nakano, Atsushi Shinohara, Jun Hatazawa

Int J Mol Sci. 2022 Aug; 23(16): 9434. Published online 2022 Aug 21. doi: 10.3390/ijms23169434

PMCID:: PMC9409053

Article PubReader PDF–2.6M Cite

Select item 938769816.

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects

Venessa Tsang, Anthony Gill, Matti Gild, Brett Lurie, Lucy Blumer, Rhonda Siddall, Roderick Clifton-Bligh, Bruce Robinson

J Clin Endocrinol Metab. 2022 Sep; 107(9): e3824–e3829. Published online 2022 Jun 1. doi: 10.1210/clinem/dgac337

PMCID:: PMC9387698

Article PubReader Cite

Select item 928236217.

Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology

Myat Han Soe, Janet M Chiang, Robert R Flavell, Elham Khanafshar, Laura Mendoza, Hyunseok Kang, Chienying Liu

J Clin Endocrinol Metab. 2022 Aug; 107(8): e3206–e3216. Published online 2022 May 12. doi: 10.1210/clinem/dgac305

PMCID:: PMC9282362

Article PubReader Cite

Select item 920649218.

Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial

Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S. Baxi, Ravinder K. Grewal, Steven M. Larson, Keith S. Pentlow, Sofia Haque, R. Michael Tuttle, Mona M. Sabra, Stephanie Fish, Laura Boucai, Jamie Walters, Ronald A. Ghossein, Venkatraman E. Seshan, Jeffrey A. Knauf, David G. Pfister, James A. Fagin, Alan L. Ho

Thyroid. March 2022; 32(3): 273–282. Published online 2022 Mar 17. doi: 10.1089/thy.2021.0565

PMCID:: PMC9206492

Article PubReader PDF–392K Cite

Select item 918121519.

Redox Homeostasis in Thyroid Cancer: Implications in Na⁺/I⁻ Symporter (NIS) Regulation

Juliana Cazarin, Corinne Dupuy, Denise Pires de Carvalho

Int J Mol Sci. 2022 Jun; 23(11): 6129. Published online 2022 May 30. doi: 10.3390/ijms23116129

PMCID:: PMC9181215

Article PubReader PDF–1.2M Cite

Select item 913219820.

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer

Lina Liu, Yuhong Shi, Qian Lai, Yuan Huang, Xue Jiang, Qian Liu, Ying Huang, Yuxiao Xia, Dongkun Xu, Zhiqiang Jiang, Wenling Tu

Front Endocrinol (Lausanne) 2022; 13: 865909. Published online 2022 May 11. doi: 10.3389/fendo.2022.865909

PMCID:: PMC9132198

Article PubReader PDF–4.7M Cite

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 116

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity